NCT03890003View on ClinicalTrials.gov

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

May 6, 2019

Study Completion Date

May 6, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

AID System

AID system

DRUG

Insulin Lispro

Individualized doses of insulin lispro administered via the AID system to maintain glycemic control, except during procedures designed to induce hyperglycemia and hypoglycemia.

Trial Locations (1)

93105

Sansum Diabetes Research Institute, Santa Barbara

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03890003 - A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes | Biotech Hunter | Biotech Hunter